\-\ Texto\\:\\ \ \(0\)\
\-\ 6\\ x\\ 6\\ cm\\ cervical\\ mass\\ with\\ infiltrated\\ surrounding\\ fat\\,\\ consistent\\ with\\ cervical\\ cancer\\.\\ \\ \ \(1\)\
\-\ there\\ are\\ several\\ prominent\\ asymmetric\\ pelvic\\ lymph\\ nodes\\ on\\ the\\ left\\ side\\.\\ \\ these\\ are\\ not\\ pathologic\\ by\\ size\\ criteria\\,\\ however\\,\\ in\\ the\\ presence\\ of\\ nearby\\ malignancy\\ these\\ may\\ represent\\ metastatic\\ disease\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ mild\\ bilateral\\ hydronephrosis\\ from\\ the\\ cervical\\ mass\\ compressing\\ both\\ ureters\\.\\ \\ additionally\\,\\ the\\ image\\ through\\ the\\ kidneys\\ demonstrates\\ delayed\\ nephrogram\\ of\\ the\\ right\\ kidney\\ secondary\\ to\\ higher\\ back\\ pressure\\ of\\ the\\ right\\ hydronephrosis\\ compared\\ with\\ the\\ left\\.\ \(0\)\
\-\ cervical\\ cancer\\ with\\ bilateral\\ hydronephrosis\ \(0\)\
\-\ cervical\\ cancer\ \(5\)\
\-\ 29\\ y\\/o\\ g6p5051\\ female\\ arrived\\ on\\ airevac\\ from\\ micronesia\\ island\\ with\\ history\\ of\\ post\\-coital\\ bleeding\\.\ \(0\)\
\-\ bilateral\\ hydronephrosis\\ should\\ always\\ cause\\ concern\\ for\\ cervical\\ cancer\\ in\\ a\\ female\\ patient\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cervical\\:\\ 0\\.14442285612054087\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.13347779588991157\ \(0\)\
\-\ \\-there\\:\\ 0\\.11518176841622647\ \(0\)\
\-\ cancer\\:\\ 0\\.08710589967022528\ \(0\)\
\-\ g6p5051\\:\\ 0\\.0683373521237713\ \(0\)\
\-\ airevac\\:\\ 0\\.0683373521237713\ \(0\)\
\-\ post\\-coital\\:\\ 0\\.0683373521237713\ \(0\)\
\-\ \\-6\\:\\ 0\\.06296411816594227\ \(0\)\
\-\ micronesia\\:\\ 0\\.06296411816594227\ \(0\)\
\-\ infiltrated\\:\\ 0\\.05048785527885622\ \(0\)\
\-\ island\\:\\ 0\\.04907450987735269\ \(0\)\
\-\ nearby\\:\\ 0\\.04845402377135629\ \(0\)\
\-\ bilateral\\:\\ 0\\.048228319286382416\ \(0\)\
\-\ nephrogram\\:\\ 0\\.04787954336706387\ \(0\)\
\-\ arrived\\:\\ 0\\.04787954336706387\ \(0\)\
\-\ ureters\\:\\ 0\\.04077651443780685\ \(0\)\
\-\ compressing\\:\\ 0\\.04013900980031095\ \(0\)\
\-\ criteria\\:\\ 0\\.036220028663371824\ \(0\)\
\-\ 29\\:\\ 0\\.03456441548276672\ \(0\)\
\-\ these\\:\\ 0\\.034478212278416125\ \(0\)\
\-\ always\\:\\ 0\\.034082773768758914\ \(0\)\
\-\ concern\\:\\ 0\\.0329548080038656\ \(0\)\
\-\ higher\\:\\ 0\\.03248484969521106\ \(0\)\
\-\ asymmetric\\:\\ 0\\.03218666147173978\ \(0\)\
\-\ kidneys\\:\\ 0\\.030486174429303313\ \(0\)\
\-\ nodes\\:\\ 0\\.02992008811135843\ \(0\)\
\-\ represent\\:\\ 0\\.02909242938712815\ \(0\)\
\-\ pathologic\\:\\ 0\\.028994919447540086\ \(0\)\
\-\ bleeding\\:\\ 0\\.02875637945787533\ \(0\)\
\-\ additionally\\:\\ 0\\.028709539810929885\ \(0\)\
\-\ compared\\:\\ 0\\.028038925524811416\ \(0\)\
\-\ female\\:\\ 0\\.027236593355780367\ \(0\)\
\-\ prominent\\:\\ 0\\.027187990128413126\ \(0\)\
\-\ pelvic\\:\\ 0\\.027187990128413126\ \(0\)\
\-\ delayed\\:\\ 0\\.026961087940040155\ \(0\)\
\-\ lymph\\:\\ 0\\.02674063882902827\ \(0\)\
\-\ pressure\\:\\ 0\\.0260149837970724\ \(0\)\
\-\ malignancy\\:\\ 0\\.02559759440156214\ \(0\)\
\-\ presence\\:\\ 0\\.024044849755481622\ \(0\)\
\-\ kidney\\:\\ 0\\.02333630585310085\ \(0\)\
\-\ side\\:\\ 0\\.022949197688093573\ \(0\)\
\-\ cause\\:\\ 0\\.022412888577922216\ \(0\)\
\-\ size\\:\\ 0\\.02220834008820753\ \(0\)\
\-\ x\\:\\ 0\\.021853227405794397\ \(0\)\
\-\ back\\:\\ 0\\.021853227405794397\ \(0\)\
\-\ surrounding\\:\\ 0\\.02177647491755632\ \(0\)\
\-\ several\\:\\ 0\\.021295293300173546\ \(0\)\
\-\ should\\:\\ 0\\.02111789567355659\ \(0\)\
\-\ image\\:\\ 0\\.020691388886027912\ \(0\)\
\-\ fat\\:\\ 0\\.02014660715412119\ \(0\)\
\-\ 6\\:\\ 0\\.019783877219960267\ \(0\)\
\-\ from\\:\\ 0\\.019634662219445154\ \(0\)\
\-\ through\\:\\ 0\\.01881362029783619\ \(0\)\
\-\ secondary\\:\\ 0\\.01851961214347913\ \(0\)\
\-\ however\\:\\ 0\\.018444713609279614\ \(0\)\
\-\ mass\\:\\ 0\\.018425752045698674\ \(0\)\
\-\ y\\/o\\:\\ 0\\.018345961471470083\ \(0\)\
\-\ are\\:\\ 0\\.01806006003921863\ \(0\)\
\-\ cm\\:\\ 0\\.017767101688503765\ \(0\)\
\-\ mild\\:\\ 0\\.017443825224272378\ \(0\)\
\-\ both\\:\\ 0\\.01691627899756683\ \(0\)\
\-\ metastatic\\:\\ 0\\.016675266694698373\ \(0\)\
\-\ consistent\\:\\ 0\\.016242622239001574\ \(0\)\
\-\ left\\:\\ 0\\.014823337508107205\ \(0\)\
\-\ may\\:\\ 0\\.014529677278280029\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014469931795761132\ \(0\)\
\-\ right\\:\\ 0\\.013978786187758397\ \(0\)\
\-\ on\\:\\ 0\\.01122311647078183\ \(0\)\
\-\ by\\:\\ 0\\.011030007001898254\ \(0\)\
\-\ disease\\:\\ 0\\.010827422800121738\ \(0\)\
\-\ not\\:\\ 0\\.009572237765441359\ \(0\)\
\-\ history\\:\\ 0\\.009148949904706072\ \(0\)\
\-\ the\\:\\ 0\\.008573599051387645\ \(0\)\
\-\ \\,\\:\\ 0\\.008394110558675578\ \(0\)\
\-\ patient\\:\\ 0\\.006640247526483628\ \(0\)\
\-\ in\\:\\ 0\\.006533290389771395\ \(0\)\
\-\ for\\:\\ 0\\.005652001152269109\ \(0\)\
\-\ with\\:\\ 0\\.004535045584879447\ \(0\)\
\-\ is\\:\\ 0\\.004358843243292446\ \(0\)\
\-\ of\\:\\ 0\\.0036125209549763854\ \(0\)\
\-\ to\\:\\ 0\\.003310605491806095\ \(0\)\
\-\ a\\:\\ 0\\.00307441706836125\ \(0\)\
\-\ \\.\\:\\ 0\\.0019263314161350692\ \(0\)\
